Expansion momentum Soleo Health is rapidly expanding its footprint through acquisitions and geographic growth, including the BluHaven and Realo Specialty Care integration in the Mid-Atlantic and Louisville expansion. This presents cross-sell opportunities to newly acquired centers and a larger national footprint for infusion services and complex specialty pharmacy partnerships.

Rare disease focus The launch of SoleoRare and recognition as a URAC Leaders in Performance Measurement Awards Program signal a dedicated Rare Disease Specialty Pharmacy capability. Target opportunities include payer and provider collaborations for rare disease therapies, reimbursement optimization, and care coordination programs.

Leadership depth New senior leaders in sales and clinical operations plus the Principal hires bring seasoned expertise and strategic growth direction. Leverage their networks to accelerate enterprise accounts, hospital systems, and specialty clinics seeking integrated home-based infusion and complex therapy services.

National access With 28 pharmacy locations and licensure in 50 states plus national nursing coverage and multiple infusion suites, Soleo Health can support scale across regions, enabling national accounts to consolidate complex therapy management with consistent quality and compliance.

Technology and accreditation A tech-enabled platform including URAC and ACHC distinctions, plus data and reimbursement capabilities, indicates strong interoperability and value evidence for outcomes-driven contracts. Focus on selling outcomes-based agreements, performance dashboards, and reimbursement optimization services to payers and providers.